AVTX Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-11-16SCHEDULE 13G/A0000921895-26-003170SEC →
2026-11-16SCHEDULE 13G/A0000919574-26-008106SEC →
2026-11-13SCHEDULE 13G0000908834-26-000525SEC →
2026-11-10SCHEDULE 13G0000093751-26-000620SEC →
2026-11-06SCHEDULE 13G/A0000315066-26-002939SEC →
2026-11-0510-Q0001534120-26-000057SEC →
2026-11-058-K0001534120-26-000056SEC →
2026-11-058-K0001104659-26-123079SEC →
2026-11-05S-3ASR0001104659-26-123072SEC →
2026-11-05424B50001104659-26-123069SEC →
2026-11-05SCHEDULE 13G/A0000315066-26-002679SEC →
2026-10-29SCHEDULE 13G0001493152-26-049273SEC →
2026-10-0240002063957-26-000009SEC →
2026-10-0240001707797-26-000017SEC →
2026-10-0240001677036-26-000009SEC →
2026-09-1840001810417-26-000023SEC →
2026-09-1140001810417-26-000021SEC →
2026-09-0140001918845-26-000031SEC →
2026-08-1940001918845-26-000029SEC →
2026-08-1940001810417-26-000019SEC →
2026-08-181440001950047-26-008317SEC →
2026-08-171440001950047-26-008276SEC →
2026-08-171440001950047-26-008273SEC →
2026-08-171440001950047-26-008220SEC →
2026-08-14SCHEDULE 13G/A0001897612-26-000606SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Avalo Therapeutics (AVTX) — Filings